BIOADAPTIVES INC
For the period ended May 20, 2024. Filed May 22, 2024.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
May 20, 2024 · Filed May 22, 2024
Contents
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): May 20, 2024
BIOADAPTIVES, INC.
(Exact Name of Registrant as Specified in its Charter)
| Delaware | 000-54949 | 46-2592228 |
|---|---|---|
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS EmployerIdentification No.) |
2620 Regatta Drive, Suite 102
Las Vegas, Nevada 89128
(Address of Principal Executive Office) (Zip Code)
(702)659-8829
Registrant's telephone number, including area code:
N/A
(former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|---|---|
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On May 20, 2024, the Shareholders of BioAdaptives Inc accepted the resignation of the Chairman of the Board Edward Jacobs for personal reasons and the resignation of Board Member Robert Ellis also for personal reasons. In the same meeting, the Shareholders elected James Keener as Chairman of the Board and currently the sole Member of the Board.
On May 20, 2024, following the shareholders meeting the Board of Directors of BioAdaptives Inc met and accepted the resignation of the CEO Edward Jacobs for personal reasons and the resignation of President Robert Ellis also for personal reasons. The Board of Directors then elected James Keener to the position of CEO and currently the sole Officer.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.